Showing results (1331-1340 of 5,257) with videos related to

Sort By:
Pageof 526
Oncology|February 12, 2009
The p53 codon 72 exon 4 BstUI polymorphism and endometrial cancer in Caucasian womenPavol Zubor, Andrea Stanclova, Karol Kajo, et al.
Oncology|February 12, 2009
The Ile646Val (2073A>G) polymorphism in the kinase-binding domain of A-kinase anchoring protein 10 and the risk of colorectal cancerMo-Jin Wang, Zong-Guang Zhou, Ling Wang, et al.
Oncology|November 29, 2008
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trialS Pignata, G Scambia, A Savarese, et al.
Oncology|February 17, 2009
Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastomaM Glas, T Hundsberger, M Stuplich, et al.
Oncology|January 1, 1978
Immunotherapy with tumor cells and BCG in the guinea pig, studied by immunological in vivo and in vitro experimentsW Rella, B Chaput
Oncology|November 6, 2010
Trimodal therapy for inflammatory breast cancer: a surgeon's perspectiveBenjamin D Li, Mark A Sicard, Fred Ampil, et al.
Oncology|March 31, 2011
A pilot feasibility study of TNFerade™ biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancerDeborah Citrin, Kevin Camphausen, Bradford J Wood, et al.
Oncology|April 14, 2011
A six-week course of bacillus Calmette-Guérin prophylaxis is insufficient to prevent tumor recurrence in nonmuscle invasive bladder cancer with strong-positive expression of p53Jong Jin Oh, Sang Hyun Ji, Don Kyoung Choi, et al.
Oncology|March 25, 2011
Clinical significance of pretreatment C-reactive protein in patients with advanced nonsquamous, non-small cell lung cancer who received gefitinibKatsuhiro Masago, Shiro Fujita, Yosuke Togashi, et al.
Oncology|June 24, 2019
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid TumorsDavid Hong, Drew Rasco, Michael Veeder, et al.
Pageof 526